Mueller Joerg, Skogseid Inger M, Benecke Reiner, Kupsch Andreas, Trottenberg Thomas, Poewe Werner, Schneider Gerd H, Eisner Wilhelm, Wolters Alexander, Müller J U, Deuschl Günther, Pinsker Marcus O, Roeste Geir K, Vollmer-Haase Juliane, Brentrup Angela, Krause Martin, Tronnier Volker, Schnitzler Alfons, Voges Jüergen, Nikkhah Guido, Vesper Jan, Naumann Markus, Volkmann Jens
Mov Disord. 2008 Jan;23(1):131-4. doi: 10.1002/mds.21783.
As part of the first randomized, sham-stimulation controlled trial on deep brain stimulation (DBS) in primary segmental or generalized dystonia, health-related quality of life (HRQoL) was assessed by SF-36. After the 3-month sham-controlled phase, significant HRQoL improvement occurred only in the active-stimulation group. The open-label extension phase resulted in a significant improvement in all SF-36 domains following 6 months of neurostimulation. These results demonstrate a favorable impact of DBS on HRQoL in primary dystonia.
作为首个针对原发性节段性或全身性肌张力障碍进行深部脑刺激(DBS)的随机、假刺激对照试验的一部分,通过SF-36评估了健康相关生活质量(HRQoL)。在为期3个月的假刺激对照阶段后,仅在主动刺激组中出现了HRQoL的显著改善。开放标签延长期在神经刺激6个月后导致所有SF-36领域都有显著改善。这些结果表明DBS对原发性肌张力障碍的HRQoL有积极影响。